Chemotherapy-Associated Tongue Hyperpigmentation and Blue Lunula

February 2013 | Volume 12 | Issue 2 | Case Reports | 223 | Copyright © February 2013


Kathleen M. Casamiquela BAa and Philip R. Cohen MDa-c

aDepartment of Dermatology, The University of Texas Medical School at Houston, Houston, TX bHealth Center, University of Houston, Houston, TX cDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX

  1. Ranawaka RR. Patterns of chromonychia during chemotherapy in patients with skin type V and outcome after 1 year of follow-up. Clin Exp Dermatol. 2009;34(8):e920-e926.
  2. Abbasi NR, Wang N. Doxorubicin-induced hyperpigmentation. Dermatol Online J. 2008;14(10):18.
  3. Rios-Buceta L, Buezo GF, Peñas PF, Dauden E, Fernandez-Herrera J, Garcia- Diez A. Palmar-plantar erythodysaesthesia syndrome and other cutaneous side-effects after treatment with Tegafur. Acta Derm Venereol. 1997;77(1):80-81
  4. Sood A, Midha V, Bansal M, Goyal A, Sharma N. Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. Indian J Gastroenterol. 2006;25(6):324.
  5. Dell’lsola S, Ialungo AM, Starnini G, Roselli P, Ghittoni G, Caturelli E. A surprising hyperpigmentation of the gums and tongue. Gut. 2008;57(12):1697, 1727.
  6. Radha Krishna Y, Itha S. What caused this lingual hyperpigmentation in a patient with chronic hepatitis C. Liver Int. 2010;30(3):416.
  7. Farshidi D, Chiu MW. Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C. J Am Acad Dermatol. 2010;62(1):164-165.
  8. de Moraes PC, Noce CW, Thomaz LA, Mautoni MC, Corrêa ME. Tongue hyperpigmentation resulting from peginterferon alfa and ribavirin combination therapy: a case report. J Am Dent Assoc. 2009;140(11):1377-1379.
  9. Fernández A, Vásquez S, Rodríguez-González L. Tongue hyperpigmentation resulting from peginterferon alfa-2a and ribavirin treatment in a Caucasian patient with chronic hepatitis C. J Eur Acad Dermatol Venereol. 2008;22(11):89-1391.
  10. Fleckman P. Basic science of the nail unit. In: Scher RK, Danial CR III, eds. Nails: Therapy, Diagnosis, Surgery. Philadelphia, PA: WB Saunders; 1990:36-51.
  11. Shibata S, Miyagi T, Iuchi I, Ohba Y, Yamamoto K. Hemoglobin M’s of the Japanese. Bull Yamaguchi Med Sch. 1967;14:141.
  12. Millns JL, Dicken CH. Herediatary acrolabial telangiectasia. A report of familial blue lips, nails, and nipples. Arch Dermatol.1979;115(4):474-478.
  13. Harker JM, Hunter D. Occupational argyria. Br J Dermatol Syph. 1935;47:441-455.
  14. Bearn AG, McKusick VA. Azure lunulae: an unusual change in the fingernails in two patients with hepatolenticular degeneration (Wilson’s disease). J Am Med Assoc. 1958;166(8):904-906.
  15. DeNicola P, Moriani M, Zavagli G. Anatomy and physiology. In: Nail Diseases in Internal Medicine. Springfield, IL: Charles C Thomas; 1974:1-28.
  16. Siddiqui Y, Rashid RM. Pseudo-blue lunula and beyond: a normal variant. Skinmed. 2010;8(6):363-364.
  17. Nixon DW. Alterations in nail pigment with cancer chemotherapy. Arch Intern Med. 1976;136(10):1117-1118.
  18. Cohen PR. The lunula. J Am Acad Dermatol. 1996;34(6):943-953.
  19. Alkhatib AA, Sessoms S. The tarnished tongue. Am J Med. 2006;119(10):832-834.
  20. Campbell GG. Peculiar pigmentation following the use of a purgative containing phenolphthalein. Br J Dermatol. 1931;43(4):186-187.
  21. Greenberg RG, Berger TG. Nail and mucocutaneous hyperpigmentation with azidothymidine therapy. J Am Acad Dermatol. 1990;22(2 Pt 2):327-330.

AUTHOR CORRESPONDENCE

Philip R. Cohen MDmitehead@gmail.com
Close Menu